Clinical everolimus experience in pediatric renal transplant patients.


OBJECTIVE Everolimus is a potent immunosuppressive agent that has antiproliferative activities. This study sought to share our experience among renal transplanted children who required conversion from calcineurin inhibitors (CNIs) to the mammalian target of rapamycin inhibitor everolimus. PATIENTS AND METHODS Exclusion criteria were multiple organ… (More)
DOI: 10.1016/j.transproceed.2013.02.076

2 Figures and Tables


  • Presentations referencing similar topics